Antithrombotic drugs

The European Society of Cardiology ( ESC ) has recommended uninterrupted anticoagulation with vitamin K antagonists during ablation and device...


Non-vitamin K antagonist oral anticoagulants ( NOACs ) are efficacious and safe antithrombotic drugs but the non-availability of an antidote...


The results from two analyses of the GLORIA-AF Registry Program examining the use of antithrombotic treatment to reduce the risk...


A new study has compared outcomes for two drugs used to prevent blood clot formation during emergency myocardial infarction treatment....


A study led by researchers at the University of North Carolina has indicated that a new anticoagulant may increase the...


In patients with myocardial infarction, risk of hospital admission for bleeding increases with the number of antithrombotic drugs used. Patients...


The FDA ( Food and Drug Administration ) has completed a safety review of Multaq ( Dronedarone ). This review...


In myocardial infarction patients, risk of hospital admission for bleeding increases with the number of antithrombotic drugs used. Patients with...


Clinical trials comparing antithrombotic therapy with placebo have shown that Warfarin ( Coumadin ) reduces the risk of stroke by...


A prospective observational analysis, coordinated by the DCRI ( Duke Clinical Research Institute ), in 387 US hospitals of...